<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-07-31T09:26:56Z</responseDate><request verb="GetRecord" identifier="oai:docta.ucm.es:20.500.14352/97617" metadataPrefix="oai_dc">https://docta.ucm.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:docta.ucm.es:20.500.14352/97617</identifier><datestamp>2024-02-15T01:27:12Z</datestamp><setSpec>com_20.500.14352_14</setSpec><setSpec>col_20.500.14352_15</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>Hepatic overexpression of cAMP-responsive element modulator α induces a regulatory T-cell response in a murine model of chronic liver disease</dc:title>
   <dc:creator>Cubero Palero, Francisco Javier</dc:creator>
   <dc:creator>Kuttkat, Nadine</dc:creator>
   <dc:creator>Mohs, Antje</dc:creator>
   <dc:creator>Ohl, Kim</dc:creator>
   <dc:creator>Hooiveld, Guido</dc:creator>
   <dc:creator>Longerich, Thomas</dc:creator>
   <dc:creator>Tenbrock, Klaus</dc:creator>
   <dc:creator>Trautwein, Christian</dc:creator>
   <dc:subject>577</dc:subject>
   <dc:subject>Hepatocellular Carcinoma</dc:subject>
   <dc:subject>Chronic liver disease</dc:subject>
   <dc:subject>Liver</dc:subject>
   <dc:subject>Nuclear factor Kappa B</dc:subject>
   <dc:subject>T Lymphocytes</dc:subject>
   <dc:subject>Ciencias Biomédicas</dc:subject>
   <dc:subject>Biología</dc:subject>
   <dc:subject>Biología celular (Biología)</dc:subject>
   <dc:subject>Medicina</dc:subject>
   <dc:subject>Gastroenterología y hepatología</dc:subject>
   <dc:subject>Inmunología</dc:subject>
   <dc:subject>24 Ciencias de la Vida</dc:subject>
   <dc:subject>2407 Biología Celular</dc:subject>
   <dc:subject>2407.99 Otras</dc:subject>
   <dc:subject>2412 Inmunología</dc:subject>
   <dc:subject>2415 Biología Molecular</dc:subject>
   <dc:subject>3299 Otras Especialidades Médicas</dc:subject>
   <dc:description>Additional material is published online only. To view please visit the journal online (http://dx.doi.org/10.1136/gutjnl-2015-311119).
1 Department of Internal Medicine III, University Hospital RWTH Aachen, Aachen, Germany
2 Department of Pediatrics, University Hospital RWTH Aachen, Aachen, Germany
3 Institute for Nutrition, Metabolism &amp; Genomics, Wageningen University &amp; Research Centre, Wageningen, Netherlands
4 Institute of Pathology, RWTH University Hospital Aachen, Aachen, Germany
Correspondence to Professor Christian Trautwein, Department of Internal Medicine III, University Hospital RWTH Aachen, Pauwelsstrasse 30, Aachen D-52074, Germany; ctrautwein@ukaachen.de
Francisco Javier Cubero, Department of Immunology, Complutense University School of Medicine, Plaza de Ramón y Cajal s/n, Madrid 28040, Spain; fcubero@ucm.es
NK and AM contributed equally. FJC and CT are joint senior authors.</dc:description>
   <dc:description>Objective: Th17 cells are a subset of CD4+ T-helper cells characterised by interleukin 17 (IL-17) production, a cytokine that plays a crucial role in inflammationassociated diseases. The cyclic AMP-responsive element modulator-α (CREMα) is a central mediator of T-cell pathogenesis, which contributes to increased IL-17 expression in patients with autoimmune disorders. Since an increased Th17 response is associated with a poor prognosis in patients with chronic liver injury, we investigated the relevance of Th17 cells for chronic liver disease (CLD) and hepatocarcinogenesis.
Design: Transgenic mice overexpressing CREMα were crossed with hepatocyte-specific Nemo knockout mice (NemoΔhepa) to generate NemoΔhepa/CREMαTg mice. The impact of CREMαTg on CLD progression was examined. Additionally, soft agar colony formation assays, in vitro
studies, adoptive transfer of bone marrow-derived cells (BMDCs) and T cells, and gene arrays in T cells were performed.
Results: 8-week-old NemoΔhepa/CREMαTg mice presented significantly decreased transaminase levels, concomitant with reduced numbers of CD11b+ dendritic cells and CD8+ T cells. CREMαTg overexpression in NemoΔhepa mice was associated with significantly reduced hepatic fibrogenesis and carcinogenesis at 52 weeks. Interestingly, hepatic stellate cell-derived retinoic acid induced a regulatory T-cell (Treg) phenotype in CREMαTg hepatic T cells. Moreover, simultaneous
adoptive transfer of BMDCs and T cells from CREMαTg into NemoΔhepa mice ameliorated markers of liver injury and hepatitis.
Conclusions: Our results demonstrate that overexpression of CREMα in T cells changes the
inflammatory milieu, attenuating initiation and progression of CLD. Unexpectedly, our study indicates that CREMα transgenic T cells shift chronic inflammation in NemoΔhepa livers towards a protective Treg response.</dc:description>
   <dc:description>ZKF (UKA, RWTH Aachen)</dc:description>
   <dc:description>Depto. de Inmunología, Oftalmología y ORL</dc:description>
   <dc:description>Fac. de Medicina</dc:description>
   <dc:description>TRUE</dc:description>
   <dc:description>pub</dc:description>
   <dc:date>2024-02-01T11:47:22Z</dc:date>
   <dc:date>2024-02-01T11:47:22Z</dc:date>
   <dc:date>2016-09-29</dc:date>
   <dc:type>journal article</dc:type>
   <dc:type>VoR</dc:type>
   <dc:identifier>https://hdl.handle.net/20.500.14352/97617</dc:identifier>
   <dc:identifier>1527-3350</dc:identifier>
   <dc:identifier>10.1136/ gutjnl-2015-311119</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>#691405</dc:relation>
   <dc:relation>Kuttkat N, Mohs A, Ohl K, Hooiveld G, Longerich T, Tenbrock K, Cubero FJ, Trautwein C. Hepatic overexpression of cAMP-responsive element modulator α induces a regulatory T-cell response in a murine model of chronic liver disease. Gut. 2017 May;66(5):908-919. doi: 10.1136/gutjnl-2015-311119</dc:relation>
   <dc:rights>Attribution-NonCommercial-NoDerivatives 4.0 International</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
   <dc:rights>open access</dc:rights>
   <dc:format>application/pdf</dc:format>
   <dc:publisher>Lippincott, Williams &amp; Wilkins</dc:publisher>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>